Vallet, Sonia
Fan, Fengjuan
Malvestiti, Stefano
Pecherstorfer, Martin
Sattler, Martin
Schneeweiss, Andreas
Schulze-Bergkamen, Henning
Opferman, Joseph T.
Cardone, Michael H.
Jäger, Dirk
Podar, Klaus http://orcid.org/0000-0002-7414-3632
Article History
Received: 22 August 2018
Accepted: 20 October 2018
First Online: 29 October 2018
Compliance with ethical standards
:
: KP received speaker honorarium from Celgene, Janssen, and Amgen. MP and KP received research support from Roche Pharmaceuticals. JTO received consultant honorarium and research support from AbbVie. DJ received consultant honorarium from Bayer, Amgen, MSD, CureVac, Roche, BMS. MHC is the co-funder, president and CEO of Eutropics, Inc. The remaining authors declare no conflict of interest.
: This study complied with current laws of Germany, Austria and USA. The collection and use of primary cells has been approved by the Ethics committee of the Medical Faculty, University of Heidelberg (Approval Number 022/2013).
: Informed consent was obtained in accordance with the Declaration of Helsinki. This article does not contain any studies with animals performed by any of the authors.